A Trial to Assess the Safety and Efficacy of Topical Salbutamol in Healthy Volunteers.
Status:
Completed
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
This will be a single centre, double-blind, placebo (vehicle) controlled, randomised, dose
escalation trial. Three concentrations of topical salbutamol gel will be compared, in a
group-wise fashion, with a placebo administration at one incision site on each arm of the
trial subjects. Each participant will be allocated to only one dosing group. The treatments
will be paired anatomically so that for each pair of sites, one closed incision site will
receive the active substance, while the other will receive placebo.
Phase:
Phase 1
Details
Lead Sponsor:
University Hospitals, Leicester
Collaborators:
Leicester Clinical Trials Unit Medical Research Council University of Leicester